kabutan

Linical Co., Ltd.(2183) Summary

2183
TSE Standard
Linical Co., Ltd.
247
JPY
-2
(-0.80%)
Apr 30, 10:08 am JST
1.54
USD
Apr 29, 9:08 pm EDT
Result
PTS
outside of trading hours
248.1
Apr 30, 9:52 am JST
Summary Chart Historical News Financial Result
PER
PBR
0.98
Yield
3.24%
Margin Trading Ratio
Stock Price
Apr 30, 2026
Opening Apr 30, 9:00 am
248 JPY 1.54 USD
Previous Close Apr 28
249 JPY 1.56 USD
High Apr 30, 9:00 am
248 JPY 1.54 USD
Low Apr 30, 9:57 am
247 JPY 1.54 USD
Volume
4,700
Trading Value
1.00M JPY 7.30K USD
VWAP
247.94 JPY 1.55 USD
Minimum Trading Value
24,700 JPY 154 USD
Market Cap
6.11B JPY 0.04B USD
Number of Trades
6
Liquidity & Number of Trades
As of Apr 30, 2026
Liquidity
Mid
1-Year Average
57
1-Year High Mar 19, 2026
466
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 0 240,600
Apr 17, 2026 0 216,600
Apr 10, 2026 0 190,300
Apr 3, 2026 0 189,800
Mar 27, 2026 0 175,600
Company Profile
Linical Co., Ltd. specializes in contract research for pharmaceutical development, focusing on Phase II and III clinical trials. The company also provides support for pharmaceutical sales.
Sector
Services
Linical Co., Ltd. primarily engages in Contract Research Organization (CRO) services for pharmaceutical development, while also offering post-marketing support services for pharmaceuticals. In its CRO business, the company undertakes various tasks including clinical trial monitoring, quality control, data management, statistical analysis, and medical writing for documents such as clinical trial protocols. Additionally, Linical provides drug discovery support services, offering consulting on development strategy planning, regulatory affairs, and approval applications for biotech venture companies. In its post-marketing support business, Linical handles planning, monitoring, and auditing services. Through these operations, Linical offers comprehensive global services spanning from drug discovery support to clinical development, and post-approval lifecycle management, including post-marketing clinical trials and research.